DRUG TRANSPORT IN THE KIDNEY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 486

70. Terada T, Inui K. 2004. Peptide transporters: structure, function, regulation and application
for drug delivery. Curr Drug Metab 5:85-94.
71. Daniel H, Kottra G. 2004. The proton oligopeptide cotransporter family SLC15 in phys-
iology and pharmacology. Pflugers Arch 447:610-618.
72. Ogihara H, Saito H, Shin BC, Terado T, Takenoshita S, Nagamachi Y, Inui K, Takata K.
1996. Immuno-localization of H + /peptide cotransporter in rat digestive tract. Biochem
Biophys Res Commun 220:848-852.
73. Shen H, Smith DE, Yang T, Huang YG, Schnermann JB, Brosius FC 3rd. 1999. Localiza-
tion of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein
in rat kidney. Am J Physiol 276:F658-F665.
74. Gray JH, Owen RP, Giacomini KM. 2004. The concentrative nucleoside transporter fam-
ily, SLC28. Pflugers Arch 447:728-734.
75. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. 2004. The equilibrative
nucleoside transporter family, SLC29. Pflugers Arch 447:735-743.
76. Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: role of ATP-
dependent transporters. Nat Rev Cancer 2:48-58.
77. Keppler D, Konig J, Buchler M. 1996. The canalicular multidrug resistance protein,
cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hep-
atocytes. Adv Enzyme Regul 37:321-333.
78. Leonard GD, Fojo T, Bates SE. 2003. The role of ABC transporters in clinical practice.
Oncologist 8:411-424.
79. Smeets PH, van Aubel RA, Wouterse AC, van den Heuvel JJ, Russel FG. 2004. Con-
tribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p -
aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
J Am Soc Nephrol 15:2828-2835.
80. van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. 2005. Human organic anion
transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with
multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 288:F327-F333.
81. Mao Q, Unadkat JD. 2005. Role of the breast cancer resistance protein (ABCG2) in drug
transport. AAPS J 7:E118-E133.
82. Tanaka Y, Slitt AL, Leazer TM, Maher JM, Klaassen CD. 2005. Tissue distribution and
hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice.
Biochem Biophys Res Commun 326:181-187.
83. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. 1994. Drug excretion
mediated by a new prototype of polyspecific transporter. Nature 372:549-552.
84. Koepsell H. 1998. Organic cation transporters in intestine, kidney, liver, and brain. Annu
Rev Physiol 60:243-266.
85. Urakami Y, Okuda M, Masuda S, Saito H, Inui K. 1998. Functional characteristics and
membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2,
mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 287:800-805.
86. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. 1997. Cloning
and functional expression of a human liver organic cation transporter. Mol Pharmacol
51:913-921.
87. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S,
Baumann C, Lang F, Busch AE, Koepsell H. 1997. Cloning and characterization of two
human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.